Morphine Drugs Global Market Report 2024

Description

Morphine drugs encompass a category of medications containing morphine, a potent opioid analgesic derived from the opium poppy plant. These drugs are employed for alleviating moderate to severe pain, typically post-surgical procedures, injuries, or in the management of conditions such as cancer.

The primary dosage forms of morphine drugs include injectable, oral, and other formulations. Injectable forms are designed for administration via injection, delivering rapid effects by bypassing the digestive system. These drugs are distributed through channels such as hospital pharmacies, retail pharmacies, and online platforms, serving various purposes such as pain management, palliative care, diarrhea suppression, anesthesia, cold and cough relief, among others. They are utilized by diverse end users including hospitals, clinics, ambulatory surgical centers, and others.

The morphine drugs market research report is one of a series of new reports from The Business Research Company that provides morphine drugs market statistics, including the morphine drugs industry's global market size, regional shares, competitors with a morphine drugs market share, detailed morphine drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the morphine drugs industry. This morphine drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The morphine drugs market size has grown strongly in recent years. It will grow from $20.50 billion in 2023 to $21.82 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth observed in the historic period can be attributed to several key factors, including an increase in the number of cancer cases, a rise in the prevalence of orthopedic diseases, an uptick in the number of surgical procedures performed, a growing aging population, and an increase in healthcare expenditure.

The morphine drugs market size is expected to see strong growth in the next few years. It will grow to $28.16 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period is expected to be driven by factors such as the increasing incidence of cancer cases, rising prevalence of pain-related conditions, heightened awareness and acceptance of palliative care, growing prevalence of chronic disorders, and expanded utilization of opioid medications. Major trends projected for this period encompass advancements in drug formulation technologies, integration of digital health solutions into healthcare practices, adoption of advanced technologies, collaborations and partnerships among healthcare entities, and the development and utilization of implantable medical devices.

The rise in chronic pain conditions is expected to drive the expansion of the morphine drugs market in the coming years. Chronic pain, a complex and persistent discomfort signaling injury or illness, has become a significant global health concern due to various factors such as aging populations, increasing obesity rates, sedentary lifestyles, mental health challenges, and environmental influences. Morphine plays a crucial role in managing chronic pain because of its high effectiveness in pain relief and its ability to be tailored to individual patient needs. This improves quality of life and allows individuals with chronic pain to function better without constant severe pain. For example, as of May 2021, according to the Government of Canada, up to 8.3 million Canadians may experience chronic pain by 2025, with an expected increase to 9.0 million by 2030. Hence, the rising prevalence of chronic pain conditions is fueling the growth of the morphine drug market.

Leading companies in the morphine drug market are focusing on developing morphine sulfate injection to enhance medical treatment options. Morphine sulfate injection is a potent opioid analgesic used for managing severe pain. Derived from opium, it acts by binding to opioid receptors in the brain and spinal cord, altering pain perception and emotional responses. For instance, Hospira, a US-based pharmaceutical and medical device company, introduced Morphine Sulfate Injection, an opioid agonist indicated for severe pain management requiring an opioid analgesic when other treatments are insufficient. It comes in various strengths and formulations, including a preservative-free version for intravenous, epidural, or intrathecal use. The labeling emphasizes associated risks such as addiction, abuse, and misuse, along with serious and potentially life-threatening effects from its use.

In January 2024, Taiwan-based pharmaceutical company CDMO Bora Pharmaceuticals Inc. acquired Upsher-Smith Laboratories Inc. for $210 million. This acquisition is aimed at strengthening Bora's presence in the generics market, potentially expanding its product range, enhancing manufacturing capacity, fostering innovation, and exploring new geographic markets. Upsher-Smith Laboratories Inc., a US-based pharmaceutical company, specializes in manufacturing morphine drugs.

Major companies operating in the morphine drugs market are Pfizer Inc., Sanofi S.A., Rusan Pharma Ltd., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sandoz AG, Viatris Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Johnson Matthey Fine Chemicals, Fresenius Kabi USA LLC, Delpharm SaS, Alvogen Inc., Mallinckrodt Pharmaceuticals, Lannett Company, Mayne Pharma Group Limited, Noramco Inc., Tasmanian Alkaloids, Napp Pharmaceuticals Limited, Alcaliber SA

North America was the largest region in the morphine drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the morphine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the morphine drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The morphine drugs market consists of sales of morphine sulfate, Roxanol oral solution, Kadian capsules, morphine injections, and Avinza capsules. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Morphine Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on morphine drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for morphine drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The morphine drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Dosage form: Injectable; Oral; Other Dosage Forms
2) By Distribution channels: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
3) By Applications: Pain Management; Palliative Care; Diarrhea Suppressant; Anesthesia; Cold And Cough Suppressant; Other Applications
4) By End Users: Hospitals And Clinics; Ambulatory Surgical Centers; Other End Users
Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Rusan Pharma Ltd.; Johnson & Johnson; Teva Pharmaceutical Industries Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18177

1. Executive Summary

2. Morphine Drugs Market Characteristics

3. Morphine Drugs Market Trends And Strategies

4. Morphine Drugs Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Morphine Drugs Market Size and Growth

5.1. Global Morphine Drugs Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Morphine Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Morphine Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Morphine Drugs Market Segmentation

6.1. Global Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Injectable
Oral
Other Dosage Forms
6.2. Global Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.3. Global Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pain Management
Palliative Care
Diarrhea Suppressant
Anesthesia
Cold And Cough Suppressant
Other Applications
6.4. Global Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals And Clinics
Ambulatory Surgical Centers
Other End Users

7. Morphine Drugs Market Regional And Country Analysis

7.1. Global Morphine Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Morphine Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Morphine Drugs Market

8.1. Asia-Pacific Morphine Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Morphine Drugs Market

9.1. China Morphine Drugs Market Overview
9.2. China Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Morphine Drugs Market

10.1. India Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Morphine Drugs Market

11.1. Japan Morphine Drugs Market Overview
11.2. Japan Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Morphine Drugs Market

12.1. Australia Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Morphine Drugs Market

13.1. Indonesia Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Morphine Drugs Market

14.1. South Korea Morphine Drugs Market Overview
14.2. South Korea Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Morphine Drugs Market

15.1. Western Europe Morphine Drugs Market Overview
15.2. Western Europe Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Morphine Drugs Market

16.1. UK Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Morphine Drugs Market

17.1. Germany Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Morphine Drugs Market

18.1. France Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Morphine Drugs Market

19.1. Italy Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Morphine Drugs Market

20.1. Spain Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Morphine Drugs Market

21.1. Eastern Europe Morphine Drugs Market Overview
21.2. Eastern Europe Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Morphine Drugs Market

22.1. Russia Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Morphine Drugs Market

23.1. North America Morphine Drugs Market Overview
23.2. North America Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Morphine Drugs Market

24.1. USA Morphine Drugs Market Overview
24.2. USA Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Morphine Drugs Market

25.1. Canada Morphine Drugs Market Overview
25.2. Canada Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Morphine Drugs Market

26.1. South America Morphine Drugs Market Overview
26.2. South America Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Morphine Drugs Market

27.1. Brazil Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Morphine Drugs Market

28.1. Middle East Morphine Drugs Market Overview
28.2. Middle East Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Morphine Drugs Market

29.1. Africa Morphine Drugs Market Overview
29.2. Africa Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Morphine Drugs Market Competitive Landscape And Company Profiles

30.1. Morphine Drugs Market Competitive Landscape
30.2. Morphine Drugs Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Sanofi S.A.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Rusan Pharma Ltd.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Johnson & Johnson
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Teva Pharmaceutical Industries Ltd.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Morphine Drugs Market Other Major And Innovative Companies

31.1. Daiichi Sankyo Company Limited
31.2. Sandoz AG
31.3. Viatris Inc.
31.4. Dr. Reddy's Laboratories Ltd.
31.5. Apotex Inc.
31.6. Hikma Pharmaceuticals PLC
31.7. Endo Pharmaceuticals Inc.
31.8. Sun Pharmaceutical Industries Ltd.
31.9. Johnson Matthey Fine Chemicals
31.10. Fresenius Kabi USA LLC
31.11. Delpharm SaS
31.12. Alvogen Inc.
31.13. Mallinckrodt Pharmaceuticals
31.14. Lannett Company
31.15. Mayne Pharma Group Limited

32. Global Morphine Drugs Market Competitive Benchmarking

33. Global Morphine Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Morphine Drugs Market

35. Morphine Drugs Market Future Outlook and Potential Analysis

35.1 Morphine Drugs Market In 2028 - Countries Offering Most New Opportunities
35.2 Morphine Drugs Market In 2028 - Segments Offering Most New Opportunities
35.3 Morphine Drugs Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer